Strong R&D in the Biopharmaceutical Industry Supports the US Pharmaceutical Packaging Market

The US pharmaceutical packaging market is estimated to grow at a CAGR of 7.1% during the forecast period. The market growth is attributed to the presence of a well-established biopharmaceutical industry in the country. 

Browse the full report description US Pharmaceutical Packaging Market Size, Share & Trends Analysis Report, By Type (Primary and Secondary), By Material Type (Plastic & Polymer, Paper & Paperboard, and Others), and Forecast 2019-2025 at https://www.omrglobal.com/industry-reports/us-pharmaceutical-packaging-market

According to the Pharmaceutical Research and Manufacturers Association (PhRMA), US firms conduct over 50% the global R&D in pharmaceuticals ($75 billion) and hold the intellectual property rights on most new medicines. The overall economic impact of the biopharmaceutical industry on the US economy is substantial. 

Moreover, the US has one of the most supportive domestic environments globally, for the development and commercialization of pharmaceuticals and that too with minimal market barriers. Such factors directly impact the growth of the pharmaceutical packaging industry of the country.

Market Coverage

• Market number available for – 2018-2025
• Base year- 2018
• Forecast period- 2019-2025
• Segment Covered- By Type and By Material
• Regions Covered- US
• Competitive Landscape- Arglass Yamamura LLC, Amcor Ltd., Berry Global Inc., WestRock Co., and West Pharmaceutical Services Inc. 

Key Questions Addressed by the Report

• What is the market growth rate?
• Which segment dominates the market in the base year?
• Which segment will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

US Pharmaceutical Packaging Market- Segmentation

By Type

• Primary
• Secondary

By Material Type

• Plastic & Polymer
• Paper & Paperboard
• Others